Clinical Trials Logo

Quizartinib clinical trials

View clinical trials related to Quizartinib.

Filter by:
  • None
  • Page 1

NCT ID: NCT04459598 Completed - Healthy Subjects Clinical Trials

A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

Start date: August 19, 2020
Phase: Phase 1
Study type: Interventional

This drug-drug interaction (DDI) study has been designed to investigate the effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of quizartinib and its major circulating active metabolite AC886.

NCT ID: NCT04459585 Completed - Healthy Subjects Clinical Trials

A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants

Start date: August 28, 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to investigate the one-way drug-drug interaction potential of quizartinib on dabigatran etexilate in healthy adult participants.